Zaloguj Zarejestruj się zadarmo

Ayala Pharmaceuticals organizacji Kapitalizacja rynkowa

Jaka jest wartość Kapitalizacja rynkowa organizacji Ayala Pharmaceuticals?

Wartość Kapitalizacja rynkowa organizacji Ayala Pharmaceuticals Inc. to $2.45M

Jaka jest definicja Kapitalizacja rynkowa?



Kapitalizacja rynkowa (Market cap) jest wartością rynkową wyemitowanych akcji spółki giełdowej i jest równa cenie akcji w tym czasie pomnożonej przez liczbę wyemitowanych akcji .

As outstanding stock is bought and sold in public markets, capitalization could be used as an indicator of public opinion of a company's net worth and is a determining factor in some forms of stock valuation.

Market capitalization is used by the investment community in ranking the size of companies, as opposed to sales or total asset figures. It is also used in ranking the relative size of stock exchanges, being a measure of the sum of the market capitalizations of all companies listed on each stock exchange. In performing such rankings, the market capitalizations are calculated at some significant date, such as 30 June or 31 December.

The total capitalization of stock markets or economic regions may be compared with other economic indicators. The total market capitalization of all publicly traded companies in the world was US$51.2 trillion in January 2007 and rose as high as US$57.5 trillion in May 2008 before dropping below US$50 trillion in August 2008 and slightly above US$40 trillion in September 2008. In 2014 and 2015, global market capitalization was US$68 trillion and US$67 trillion, respectively.

Kapitalizacja rynkowa firm w Health Care sektor na NASDAQ w porównaniu do Ayala Pharmaceuticals

Czym się zajmuję organizacja Ayala Pharmaceuticals?

advaxis (nasdaq: adxs) is a late -stage biotechnology company developing multiple cancer immunotherapies based on its proprietary platform that redirects the immune system to kill cancer. the advaxis technology, using bioengineered live attenuated bacteria, listeria monocytogenes (lm), actively suppresses key components in the tumor microenvironment that contribute to the tumors growth and protection from immunologic attack.

Firmy z kapitalizacja rynkowa podobne do Ayala Pharmaceuticals